The purpose of this study is to compare open abdominal incisional hernia repair using XenMATRIX biologic mesh versus repair with their own tissue. This study will provide information in determining if a biological mesh is necessary to provide a sturdy repair for a ventral hernia.
This study will involve comparison of open abdominal incisional hernia repair with XenMATRIX biologic graft versus repair with native tissue. The current study seeks to evaluate XenMATRIXTM, an FDA approved biologic graft for repairing contaminated abdominal wall defects. This study will provide significant insight for the reconstructive surgeon and patient to determine whether a biologic graft is necessary for the reconstruction of a contaminated ventral hernia repair to provide a durable single staged repair.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
9
Use of XenMATRIX mesh in the repair of contaminated ventral hernia repair
Abdominal ventral hernia repair with native tissue
University Hospitals Case Medical Center
Cleveland, Ohio, United States
The Incidence of Postoperative Hernia Recurrence
Time frame: two years after surgery date
Compare the Short-term Clinical Outcomes of Postoperative Wound Events
Time frame: two years after surgery date
Length of Hospital Stay
Participants will be followed for the duration of the hospital stay, an expected average of 1 week
Time frame: Number of days up to 1 week
Length of Resource Utilization
Time frame: two years after surgery date
Antibiotic Usage and Days
Time frame: two years after surgery date
Resumption of Activities of Daily Living
Time frame: two years after surgery date
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.